A Cost-Effectiveness Analysis of Vaccinating The Elderly with The 23-Valent Pneumococcal Polysaccharide Vaccine (Ppv23) Compared To No Vaccination, The 13-Valent Pneumococcal Conjugate Vaccine (Pcv13), or Pcv13 Followed by Ppv23 in Brazil
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.2909
https://www.valueinhealthjournal.com/article/S1098-3015(17)33243-6/fulltext
Title :
A Cost-Effectiveness Analysis of Vaccinating The Elderly with The 23-Valent Pneumococcal Polysaccharide Vaccine (Ppv23) Compared To No Vaccination, The 13-Valent Pneumococcal Conjugate Vaccine (Pcv13), or Pcv13 Followed by Ppv23 in Brazil
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)33243-6&doi=10.1016/j.jval.2017.08.2909
First page :
A930
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2680